Abstract
The Mdm2 proto-oncogene is amplified and over-expressed in a variety of tumors. One of the major functions of Mdm2 described to date is its ability to modulate the levels and activity of the tumor suppressor protein p53. Mdm2 binds to the N-terminus of p53 and, through its action as an E3 ubiquitin ligase, targets p53 for rapid proteasomal degradation. Mdm2 can also bind to other cellular proteins such as hNumb, E2F1, Rb and Akt; however, the biological significance of these interactions is less clear. To gain insight into the function of Mdm2 in vivo, we have generated a transgenic Drosophila strain bearing the mouse Mdm2 gene. Ectopic expression of Mdm2, using the UAS/GAL4 system, causes eye and wing phenotypes in the fly. Analysis of wing imaginal discs from third instar larvae showed that expression of Mdm2 induces apoptosis. Crosses did not reveal genetic interactions between Mdm2 and the Drosophila homolog of E2F, Numb and Akt. These transgenic flies may provide a unique experimental model for exploring the molecular interactions of Mdm2 in a developmental context.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Alkhalaf M, Ganguli G, Messaddeq N, Le Meur M, Wasylyk B . 1999 Oncogene 18: 1419–1434
Barak Y, Gottlieb E, Juven-Gershon T, Oren M . 1994 Genes Dev. 8: 1739–1749
Brand AH, Perrimon N . 1993 Development 118: 401–415
Brodsky MH, Nordstrom W, Tsang G, Kwan E, Rubin GM, Abrams JM . 2000 Cell 101: 103–113
Brown DR, Thomas CA, Deb SP . 1998 EMBO J. 17: 2513–2525
Chen L, Marechal V, Moreau J, Levine AJ, Chen J . 1997 J. Biol. Chem. 272: 22966–22973
Caspari T . 2000 Curr. Biol. 10: R315–317
Chang HC, Karim FD, O'Neill EM, Rebay I, Solomon NM, Therrien M, Wassarman DA, Wolff T, Rubin GM . 1994 Cold Spring Harb. Symp. Quant. Biol. 59: 147–153
Chen J, Marechal V, Levine AJ . 1993 Mol. Cell. Biol. 13: 4107–4114
Erhardt P, Tomaselli KJ, Cooper GM . 1997 J. Biol. Chem. 272: 15049–15052
Fakharzadeh SS, Trusko SP, George DL . 1991 EMBO J. 10: 1565–1569
Ganguli G, Abecassis J, Wasylyk B . 2000 EMBO J. 19: 5135–5147
Gottlieb TM, Leal JFM, Seger R, Taya Y, Oren M . 2002 Oncogene in press
Haupt Y, Maya R, Kazaz A, Oren M . 1997 Nature 387: 296–299
Hay BA, Wolff T, Rubin GM . 1994 Development 120: 2121–2129
Honda R, Tanaka H, Yasuda H . 1997 FEBS Lett. 420: 25–27
Jin S, Martinek S, Joo WS, Wortman JR, Mirkovic N, Sali A, Yandell MD, Pavletich NP, Young MW, Levine AJ . 2000 Proc. Natl. Acad. Sci. USA 97: 7301–7306
Johnson-Pais T, Degnin C, Thayer MJ . 2001 Proc. Natl. Acad. Sci. USA 98: 2211–2216
Jones SN, Hancock AR, Vogel H, Donehower LA, Bradley A . 1998 Proc. Natl. Acad. Sci. USA 95: 15608–15612
Juven-Gershon T, Oren M . 1999 Mol. Med. 5: 71–83
Juven-Gershon T, Shifman O, Unger T, Elkeles A, Haupt Y, Oren M . 1998 Mol. Cell. Biol. 18: 3974–3982
Kubbutat MH, Jones SN, Vousden KH . 1997 Nature 387: 299–303
Lohrum MA, Vousden KH . 2000 Trends Cell Biol. 10: 197–202
Lundgren K, Montes de Oca Luna R, McNeill YB, Emerick EP, Spencer B, Barfield CR, Lozano G, Rosenberg MP, Finlay CA . 1997 Genes Dev. 11: 714–725
Martin K, Trouche D, Hagemeier C, Sorensen TS, La Thangue NB, Kouzarides T . 1995 Nature 375: 691–694
Mayo LD, Donner DB . 2001 Proc. Natl. Acad. Sci. USA 98: 11598–11603
Meier P, Silke J, Leevers SJ, Evan GI . 2000 EMBO J. 19: 598–611
Momand J, Wu HH, Dasgupta G . 2000 Gene 242: 15–29
Momand J, Zambetti GP, Olson DC, George D, Levine AJ . 1992 Cell 69: 1237–1245
Oliner JD, Pietenpol JA, Thiagalingam S, Gyuris J, Kinzler KW, Vogelstein B . 1993 Nature 362: 857–860
Ollmann M, Young LM, Di Como CJ, Karim F, Belvin M, Robertson S, Whittaker K, Demsky M, Fisher WW, Buchman A, Duyk G, Friedman L, Prives C, Kopczynski C . 2000 Cell 101: 91–101
Pochampally R, Fodera B, Chen L, Shao W, Levine EA, Chen J . 1998 Oncogene 17: 2629–2636
Reinke V, Bortner DM, Amelse LL, Lundgren K, Rosenberg MP, Finlay CA, Lozano G . 1999 Cell Growth Differ. 10: 147–154
Spradling AC, Rubin GM . 1983 Cell 34: 47–57
Srinivasan A, Roth KA, Sayers RO, Shindler KS, Wong AM, Fritz LC, Tomaselli KJ . 1998 Cell Death Differ. 5: 1004–1016
Sun P, Dong P, Dai K, Hannon GJ, Beach D . 1998 Science 282: 2270–2272
Xiao ZX, Chen J, Levine AJ, Modjtahedi N, Xing J, Sellers WR, Livingston DM . 1995 Nature 375: 694–698
Acknowledgements
We thank H Steller, E Schejter, T Volk and L Glazer for stimulating discussions and valuable advice. We are grateful to Idun Pharmaceuticals for the CM1 antibody, and to Y Jan, A Manoukian, W Du, H Steller, Exelixis Inc., and the Bloomington Stock Center for generously providing fly strains. We would like to thank the members of the Shilo and Oren labs for their support and advice throughout this work. This work was supported in part by grant RO1 CA 40099 from the National Cancer Institute and by Yad Abraham Center for Cancer Diagnosis and Therapy. A Folberg-Blum was recipient of a Clore Post-Doctoral Fellowship from the Weizmann Institute of Science throughout this work.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Folberg-Blum, A., Sapir, A., Shilo, BZ. et al. Overexpression of mouse Mdm2 induces developmental phenotypes in Drosophila. Oncogene 21, 2413–2417 (2002). https://doi.org/10.1038/sj.onc.1205305
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1205305
Keywords
This article is cited by
-
NUMB facilitates autophagy initiation through targeting SCFβ-TrCP2 complex
Cell Death & Differentiation (2022)
-
Towards reconstructing the dipteran demise of an ancient essential gene: E3 ubiquitin ligase Murine double minute
Development Genes and Evolution (2020)
-
Mdm2 promotes Cdc25C protein degradation and delays cell cycle progression through the G2/M phase
Oncogene (2017)